A novel RealTime HIV-1 Qualitative assay for the detection of HIV-1 nucleic acids in dried blood spots and plasma

Journal of Virological Methods

Volumn 178, Issue 1-2, 2011, Pages 216-224

  Huang, Shihai ^a   Erickson, Brian ^a   Mak, Wai Bing ^a   Salituro, John ^a   Abravaya, Klara ^a  

^a Abbott Molecular Inc   (United States)

Author keywords

Dried blood spots; Real time PCR; RealTime HIV 1 Qualitative

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NUCLEIC ACID; VIRUS DNA;

ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; DRIED BLOOD SPOTS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; NONHUMAN; PEDIATRICS; PLASMA; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; REAL TIME HUMAN IMMUNODEFICIENCY VIRUS 1 QUALITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS CONCENTRATION; VIRUS DETECTION;

ADULT; BLOOD; DESICCATION; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; INFANT; PLASMA; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80955148865     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.09.015     Document Type: Article

References (45)

1. Barre-Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868-871.
2. Bolivar H., Geffin R., Manzi G., Fischl M.A., Holzmayer V., Mak W.B., Abravaya K., Hackett J. The challenge of HIV-1 genetic diversity: discordant CD4+ T-Cell count and viral load in an untreated patient infected with a subtype F strain. J. Acquir. Immune Defic. Syndr. 2009, 52:659-661.
3. Brennan C.A., Bodelle P., Coffey R., Harris B., Holzmayer V., Luk K.C., Swanson P., Yamaguchi J., Vallari A., Devare S.G., Schochetman G., Hackett J. HIV global surveillance: foundation for retroviral discovery and assay development. J. Med. Virol. 2006, 78(Suppl. 1):S24-S29.
4. Busch M.P., Satten G.A. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am. J. Med. 1997, 102:117-124. discussion 125-126.
5. Cartwright C.P. The changing epidemiology of HIV/AIDS at a Minnesota hospital: impact of demographic change and viral diversity. J. Med. Virol. 2006, 78(Suppl. 1):S19-S21.
6. Creek T.L., Sherman G.G., Nkengasong J., Lu L., Finkbeiner T., Fowler M.G., Rivadeneira E., Shaffer N. Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences. Am. J. Obstet. Gynecol. 2007, 197:S64-S71.
7. Curran J.W., Jaffe H.W., Hardy A.M., Morgan W.M., Selik R.M., Dondero T.J. Epidemiology of HIV infection and AIDS in the United States. Science 1988, 239:610-616.
8. Daar E.S., Little S., Pitt J., Santangelo J., Ho P., Harawa N., Kerndt P., Glorgi J.V., Bai J., Gaut P., Richman D.D., Mandel S., Nichols S. Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann. Intern. Med. 2001, 134:25-29.
9. Daar E.S., Pilcher C.D., Hecht F.M. Clinical presentation and diagnosis of primary HIV-1 infection. Curr. Opin. HIV AIDS 2008, 3:10-15.
10. Finney D.J. Probit Analysis 1971, Cambridge University Press, Cambridge. 3rd ed.
11. Fiscus S.A., Cheng B., Crowe S.M., Demeter L., Jennings C., Miller V., Respess R., Stevens W. HIV-1 viral load assays for resource-limited settings. PLoS Med. 2006, 3:e417.
12. Gallo R.C., Salahuddin S.Z., Popovic M., Shearer G.M., Kaplan M., Haynes B.F., Palker T.J., Redfield R., Oleske J., Safai B., White G., Foster P., Markham P.D.L. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224:500-503.
13. Hackett J., Luk K.C., Swanson P. Integrase inhibitor resistance-associated mutations have no impact on performance of the Abbott RealTime HIV-1 assay. 8th European HIV Drug Resistance Workshop, Abstract 43 2010.
14. Hecht F.M., Busch M.P., Rawal B., Webb M., Rosenberg E., Swanson M., Chesney M., Anderson J., Levy J., Kahn J.O. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002, 16:1119-1129.
15. Huang S., Salituro J., Tang N., Luk K.C., Hackett J., Swanson P., Cloherty G., Mak W.B., Robinson J., Abravaya K. Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR. Nucleic Acids Res. 2007, 35:e101.
16. Huang S., Tang N., Mak W.B., Erickson B., Salituro J., Li Y., Krumpe E., Schneider G., Yu H., Robinson J., Abravaya K. Principles and analytical performance of Abbott RealTime High Risk HPV test. J. Clin. Virol. 2009, 45(Suppl. 1):S13-S17.
17. Johanson J., Abravaya K., Caminiti W., Erickson D., Flanders R., Leckie G., Marshall E., Mullen C., Ohhashi Y., Perry R., Ricci J., Salituro J., Smith A., Tang N., Vi M., Robinson J. A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. J. Virol. Methods 2001, 95:81-92.
18. Kahn J.O., Walker B.D. Acute human immunodeficiency virus type 1 infection. N. Engl. J. Med. 1998, 339:33-39.
19. Leelawiwat W., Young N.L., Chaowanachan T., Ou C.Y., Culnane M., Vanprapa N., Waranawat N., Wasinrapee P., Mock P.A., Tappero J., McNicholl J.M. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J. Virol. Methods 2009, 155:109-117.
20. Lin H.H., Gaschen B.K., Collie M., El-Fishaway M., Chen Z., Korber B.T., Beatrice S.T., Zhang L. Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City. J. Acquir. Immune Defic. Syndr. 2006, 41:399-404.
21. Marshall R., Chernesky M., Jang D., Hook E.W., Cartwright C.P., Howell-Adams B., Ho S., Welk J., Lai-Zhang J., Brashear J., Diedrich B., Otis K., Webb E., Robinson J., Yu H. Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 2007, 45:747-751.
22. Nduati R., John G., Mbori-Ngacha D., Richardson B., Overbaugh J., Mwatha A., Ndinya-Achola J., Bwayo J., Onyango F.E., Hughes J., Kreiss J. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000, 283:1167-1174.
23. Nesheim S., Palumbo P., Sullivan K., Lee F., Vink P., Abrams E., Bulterys M. Quantitative RNA testing for diagnosis of HIV-infected infants. J. Acquir. Immune Defic. Syndr. 2003, 32:192-195.
24. Ou C.Y., Yang H., Balinandi S., Sawadogo S., Shanmugam V., Tih P.M., Adje-Toure C., Tancho S., Ya L.K., Bulterys M., Downing R., Nkengasong J.N. Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. J. Virol. Methods 2007, 144:109-114.
25. Palumbo P.E., Raskino C., Fiscus S., Pahwa S., Fowler M.G., Spector S.A., Englund J.A., Baker C.J. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA 1998, 279:756-761.
26. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents 2011, Department of Health and Human Services, January 10, 2011, pp. 1-166. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (accessed 24.04.11).
27. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection 2010, August 16, 2010, pp. 1-219. Available at http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf (accessed 24.04.11).
28. Popovic M., Sarngadharan M.G., Read E., Gallo R.C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984, 224:497-500.
29. Rakusan T.A., Parrott R.H., Sever J.L. Limitations in the laboratory diagnosis of vertically acquired HIV infection. J. Acquir. Immune Defic. Syndr. 1991, 4:116-121.
30. Read J.S., Committee on Pediatric AIDS, American Academy of Pediatrics Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics 2007, 120:e1547-e1562.
31. Rouet F., Sakarovitch C., Msellati P., Elenga N., Montcho C., Viho I., Blanche S., Rouzioux C., Dabis F., Leroy V. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics 2003, 112:e289.
32. Schochetman G., George J.R. AIDS Testing: A Comprehensive Guide to Technical, Medical, Social, Legal, and Management Issues 1994, Springer-Verlag, New York.
33. Swanson P., Devare S.G., Hackett J. Molecular characterization of 39 HIV-1 isolates representing groupM (subtypes A-G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res. Hum. Retrovir. 2003, 19:625-629.
34. Stevens W., Sherman G., Downing R., Parsons L.M., Ou C.Y., Crowley S., Gershy-Damet G.M., Fransen K., Bulterys M., Lu L., Homsy J., Finkbeiner T., Nkengasong J.N. Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis. Open AIDS J. 2008, 2:17-25.
35. Tang N., Huang S., Salituro J., Mak W.B., Cloherty G., Johanson J., Li Y.H., Schneider G., Robinson J., Hackett J., Swanson P., Abravaya K. A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples. J. Virol. Methods 2007, 146:236-245.
36. Thibault V., Pichoud C., Mullen C., Rhoads J., Smith J.B., Bitbol A., Thamm S., Zoulim F. Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infections. J. Clin. Microbiol. 2007, 45:3948-3953.
37. Violari A., Cotton M.F., Gibb D.M., Babiker A.G., Steyn J., Madhi S.A., Jean-Philippe P., McIntyre J.A. Early antiretroviral therapy and mortality among HIV-infected infants. N. Engl. J. Med. 2008, 359:2233-2244.
38. Weber B. Screening of HIV infection: role of molecular and immunological assays. Expert Rev. Mol. Diagn. 2006, 6:399-411.
39. WHO Early Detection of HIV Infection in Infants and Children. Guidance Note on the Selection of Technology for the Early Diagnosis of HIV in Infants and Children May 2007, World Health Organization, Geneva, Available at http://www.who.int/hiv/paediatric/EarlydiagnostictestingforHIVVer_Final_May07.pdf (accessed 3.05.11).
40. WHO, UNAIDS and UNICEF Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2009 September 2009, World Health Organization, Geneva, Available at http://www.who.int/hiv/pub/2009progressreport/en/index.html (accessed 3.05.11).
41. WHO Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach-2010 Revision 2010, World Health Organization, Geneva, Available at http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html (accessed 15.01.11).
42. WHO WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children 2010, World Health Organization, Geneva, Available http://www.who.int/hiv/pub/paediatric/diagnosis/en/index.html (accessed 15.01.11).
43. Wong E.Y., Hewlett I.K. HIV diagnostics: challenge and opportunities. HIV Ther. 2010, 4:399-412.
44. Young N.L., Shaffer N., Chaowanachan T., Chotpitayasunondh T., Vanparapar N., Mock P.A., Waranawat N., Chokephaibulkit K., Chuachoowong R., Wasinrapee P., Mastro T.D., Simonds R.J. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J. Acquir. Immune Defic. Syndr. 2000, 24:401-407.
45. Young T.P., Cloherty G., Fransen S., Napolitano L., Swanson P., Herman C., Parkin N.T., Hackett J. Performance of the Abbott RealTime HIV-1 viral load assay is not impacted by integrase inhibitor resistance-associated mutations. J. Clin. Microbiol. 2011, 49:1631-1634.